BDLIB
VRTX icon

Banque de Luxembourg Investments (BLI)’s Vertex Pharmaceuticals VRTX Stock Holding History

Banque de Luxembourg Investments (BLI)’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.86M Buy
7,700
+2,200
+40% +$975K 0.14% 137
2026
Q1 		$2.46M Hold
5,500
– – 0.07% 148
2025
Q4 		$2.5M Sell
5,500
-700
-11% -$302K 0.07% 151
2025
Q3 		$2.45M Sell
6,200
-300
-5% -$125K 0.07% 144
2025
Q2 		$2.87M Buy
+6,500
New +$3M 0.08% 149

Other funds holding VRTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Banque de Luxembourg Investments (BLI)'s VRTX Position: Q2 2026 in Review

Banque de Luxembourg Investments (BLI) increased its Vertex Pharmaceuticals (VRTX) stake by 40% in Q2 2026, buying an estimated $975K and bringing the position to 7,700 shares worth $3.86M. The position accounts for 0.14% of the portfolio, ranked #137.

Banque de Luxembourg Investments (BLI) first reported a position in VRTX in Q2 2025 and has held it in 5 quarters since. 1,020 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Banque de Luxembourg Investments (BLI) held 7,700 shares of Vertex Pharmaceuticals worth $3.86M as of Q2 2026.
  • Banque de Luxembourg Investments (BLI) bought 2,200 Vertex Pharmaceuticals shares in Q2 2026, an estimated $975K.
  • Vertex Pharmaceuticals made up 0.14% of Banque de Luxembourg Investments (BLI)'s portfolio in Q2 2026, its #137 holding.
  • Banque de Luxembourg Investments (BLI) first reported a position in Vertex Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
  • 1,020 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Banque de Luxembourg Investments (BLI)'s 13F filing for Q2 2026, filed 10 Aug 2026.